ConductScience.org, home

Paper6286502

[Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].

Schwigon CD. Infection, 1982. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)]. Papers, record 6286502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6286502

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].
PubMed
Journal
Infection
PubMed
Year
1982
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schwigon CDC D

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
CefotaximeMajor topic
Critical CareMajor topic
Lung DiseasesMajor topic
PenicillinsMajor topic
TicarcillinMajor topic
Aged
Drug Combinations
Female
Furosemide
Humans
Kidney
Male

Source PubMed

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1422,252[Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].Infection1979https://conductscience.org/library/papers/422252PubMed
26,252,153Cefotaxime in the treatment of lower respiratory tract infections.J Antimicrob Chemother1980https://conductscience.org/library/papers/6252153PubMed
34,871,700The importance of underlying disease in patients with gram-negative bacteremia.Arch Intern Med1968https://conductscience.org/library/papers/4871700PubMed
46,252,156Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.J Antimicrob Chemother1980https://conductscience.org/library/papers/6252156PubMed
54,218,163[Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].Dtsch Med Wochenschr1974https://conductscience.org/library/papers/4218163PubMed
6100,271Routine methods and their reliability for assessment of glomerular filtration rate in adults, with special reference to total [51Cr]EDTA plasma clearance.Dan Med Bull1978https://conductscience.org/library/papers/100271PubMed
7437,897[In vitro testing of newer cephalosporins (author's transl)].Infection1979https://conductscience.org/library/papers/437897PubMed
84,210,892Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections.Chemotherapy1974https://conductscience.org/library/papers/4210892PubMed
91,086,018[Gentamicin and ototoxicity. A prospective study].Ugeskr Laeger1976https://conductscience.org/library/papers/1086018PubMed
101,107,435Pharmacokinetics of ticarcillin in patients with abnormal renal function.J Infect Dis1976https://conductscience.org/library/papers/1107435PubMed
1190,896Nephrotoxicity of cefotaxime.Lancet1979https://conductscience.org/library/papers/90896PubMed
121,095,500[Aminoglycoside antibiotics from clinical viewpoint].Int J Clin Pharmacol Biopharm1975https://conductscience.org/library/papers/1095500PubMed
13672,591[Kidney tolerance of cephalosporin antibiotics: cephoxitin and HR 756, experimental studies].Med Welt1978https://conductscience.org/library/papers/672591PubMed
14795,372Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/795372PubMed
156,252,154Treatment of acute exacerbations of chronic bronchitis with cefotaxime: a controlled clinical trial.J Antimicrob Chemother1980https://conductscience.org/library/papers/6252154PubMed
16423,751[Clinical experience with a new cephalosporin derivative, Cefotaxim].Med Welt1979https://conductscience.org/library/papers/423751PubMed
17412,648Antimicrobial synergism in the therapy of gram-negative rod bacteremia.Chemotherapy1978https://conductscience.org/library/papers/412648PubMed
18108,220Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.Infection1979https://conductscience.org/library/papers/108220PubMed
196,252,169Management of severe systemic infections caused by multiple resistant organisms.J Antimicrob Chemother1980https://conductscience.org/library/papers/6252169PubMed
20406,807[Kidney damage due to drugs and its exact diagnosis].Anasthesiol Intensivmed Prax1977https://conductscience.org/library/papers/406807PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
8,314,290[Parenteral cephalosporins for the treatment of lower respiratory tract infections].Infection1993https://conductscience.org/library/papers/8314290

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6286502

GET https://conductscience.org/api/papers/v1/6286502/authors